Farrell Michael J. sold 4,993 shares of RESMED INC at $235.35 for −$1.18M on Nov 9, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chairman and CEO
Chairman and CEO
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$1,175,089.07Shares × reported price
Shares traded
4,993ResMed Common Stock
Price per share
$235.35Reported price. Read footnotes for ranges.
% of reported position traded
1.03%This security and ownership context
Holdings after
479,803Direct
Trade date
Nov 9, 2026Sell
Filed
Nov 12, 2026, 6:04 AM ET3-day reporting delay
Accession
0000943819-26-000091Code S · Transaction 398157
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 484,796 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Option exercise683$146.34$99,950.22Trade 398155
Nov 9, 2026Option exercise4,310$146.34$630,725.40Trade 398156
Nov 9, 2026Option exercise683$0.00$0Trade 398158
Nov 9, 2026Option exercise4,310$0.00$0Trade 398159
5 transaction rows in this filing. Joint filers share the same rows.

RMD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RMD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −2.2%1w ago −1%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024. F2: This transaction was executed in multiple trades at prices ranging from $231.7956 - $237.600. The price reported above reflects the weighted average sale price. F3: Represents date options first become exercisable. Options vest 1/3 per year F4: Represents date options first become exercisable. Options vest 1/3 per year